Coronavirus shows U.S. too dependent on cheap medical imports, USTR says


© Reuters. U.S.-Mexico-Canada Agreement (USMCA) signing in Mexico City

WASHINGTON (Reuters) – U.S. Representative Robert Lighthizer on Monday said the United States would seek to promote more domestic manufacturing of key medical supplies in light of the strategic vulnerabilities laid bare by the pandemic.

Lighthizer told trade ministers from the Group of 20 major economies (G20) that Washington agreed there was a need to resolve supply chain disruptions and be aware of the impact of its actions on neighbors.

“Unfortunately, like others, we are learning in this that over-dependence on other countries as a source of cheap medical products and supplies has created a strategic vulnerability to our ,” Lighthizer said.

Article continues below Advertisement...

“For the United States, we are encouraging diversification of supply chains and seeking to promote more manufacturing at home.”

He warned against efforts to use the and economic crisis to push “other agendas,” either in trade or elsewhere, and said that such efforts would sow distrust, however. He did not elaborate.

Some U.S. officials are concerned that China could seize on the crisis to push for tariff relief before fulfilling its purchase commitments under a Phase 1 U.S.-China trade deal signed in January.

Some U.S. businesses hit by the tariffs have also urged Washington to provide relief at a time of widespread shutdowns across the United States aimed at curbing the spread of the virus. Others are pressuring the Trump administration to keep the tariffs intact, however.

White House trade adviser Peter Navarro last week denied the Trump administration was considering a three-month deferral of tariff payments on imported goods, saying such a move would “enrich China at the expense of American workers.”

Navarro is also crafting an executive order that would expand “Buy America” provisions to the medical and pharmaceutical sectors – a change that Chinese officials have described as unrealistic and unwise.

Navarro last week said 97% of antibiotics sold in the United States came China.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest forms possible.



Please enter your comment!
Please enter your name here